Advertisement

Topics

Companies Related to "CHMP First Biosimilar Herceptin Another Version Humira" [Most Relevant Company Matches] RSS

13:20 EST 18th December 2017 | BioPortfolio

Here are the most relevant search results for "CHMP First Biosimilar Herceptin Another Version Humira" found in our extensive corporate database of over 50,000 company records.

Showing "CHMP First Biosimilar Herceptin Another Version Humira" Companies 1–25 of 82

Relevant

Celltrion Inc.

Headquartered in Incheon, Korea, Celltrion is a leading biopharmaceutical company, specializing in research, development and manufacture of biosimilar and innovative drugs. Celltrion strives to provide more affordable biosimilar mAbs to patients who previously had limited access to advanced therapeutics. Celltrion received FDA and EMA approval for Inflectr...


Alvotech

Alvotech is a powerful new player in the field of biopharmaceuticals, where current portfolio assets include biosimilar versions of leading monoclonal antibodies molecules. Alvotech is proud to offer its biologics manufacturing capabilities to its partners and to cooperate in the commercialization of its own developed biosimilar pipeline. Its state of the ...

Therapeutic Proteins International, LLC

TPI is a fully integrated developer and manufacturer of biosimilar recombinant protein and antibody products. Located in Chicago, TPI is exclusively focused on increasing global access to high quality biologic products by bringing safe, cost effective biosimilar products to patients worldwide. TPI’s fully-integrated process, characterization expertise...


Therapeutic Proteins International

Therapeutic Proteins International, LLC (TPI) is a fully integrated manufacturer of biosimilar recombinant protein products. TPI’s vision is to produce high quality, life-altering biologics accessible and affordable to patients around the globe. The company’s application of its groundbreaking proprietary process and patented manufacturing platfor...

Celltrion Healthcare

Satellite symposium 3a: Remsima™, the 1st biosimilar monoclonal antibody, Friday 20 February 07:15-08:15

Acorn NMR Inc.

NUTS (NMR Utility Transform Software) is being ported to the wxWidgets open source class library. This allows the same source code to compile natively on different platforms: Microsoft Windows, Apple OSX, Linux and several other platforms such as Solaris. Due to several requests for a Mac OSX version of NUTS, we are currently targeting Windows and Mac OSX. While a Linux port is possible, based on ...

QS-Quote

QS-Quote software developed by Peter Higgins and his company dataSCIENCE, has been continuously licensed by market leading technology solution providers in North America since 1994 and utilized by thousands of mobile and deskbound users The web based version of QS-Quote, launched in 2002, was designed specifically to meet the needs of sales professionals in the indirect channel - manufacturer, dis...

Conkwest, Inc.

Conkwest is an innovative immuno-oncology company that is developing and commercializing a portfolio of highly potent and selective cellular therapies for the treatment of cancers and serious viral infections. Conkwest’s products are based on its proprietary cancer-killing cell line Neukoplast™ (also known as NK-92), the only known cell line that ...

Probably Relevant

EPIRUS Biopharmaceuticals, Inc.

EPIRUS is focusing on the central development of a broad pipeline of biosimilar monoclonal antibodies and therapeutic proteins, optimized for use within the SCALE™ disposable manufacturing system, and designed to be deployed in an “In Market, For Market” ™ manufacturing configuration.

Samarind Limited

Samarind Limited, based five miles outside the historic city of Chester, was founded in 1987 and has grown steadily to become one of the leading life sciences software houses in the UK. Originally a bespoke software house, Samarind developed the first version of its flagship product Samarind RMS in 2003. Since then it has undergone a number of major upgrades and now stands at version 4. In 200...

Therapeutic Proteins Ltd.,

Therapeutic Proteins Ltd., is a world class global developer and supplier of biosimilar recombinant therapeutic proteins. Manufactured in fully cGMP compliant facilities in Europe and North America, our products meet or exceed all worldwide compendia specifications available as of date.

Pharmacon Research GmbH

Pharmacon Research is an independent contract research organization (CRO) with headquarters in Berlin and clinical sites in Prague, Warsaw, Bratislava and Budapest. Founded in 1992 by the management of a successful Phase I unit, Pharmacon Research focuses on specific Phase I studies in patients and symptomatic subjects and on early Phase II studies (dose finding, proof of concept). Irrespective of...

BIOCAD

Based in St. Petersburg, Russia, joint-stock company BIOCAD is a leading Russian private biopharmaceutical company, specializing in the research, development and manufacture of generic, biosimilar, and innovative drugs. BIOCAD works to provide more affordable therapeutic proteins and small-molecule generics to patients who previously had limited access to ...

A&G Pharmaceutical Incorporated

A&G Pharmaceutical, Inc. (A&G) was incorporated in Delaware on June 6, 2000, as a "C" Corporation, to make use of two proprietary technologies that are unique to the Company. A&G is located in Baltimore, Maryland, and consists of two distinct but integrate divisions: 1) the Pharmaceutical Division and 2) the Monoclonal Antibody Services Division. Pharmaceutical Division Breast cancer is the most ...

Shaun T

Shaun T is a world-renowned health and fitness expert, TV host, motivator and creator of the best-selling fitness programs including INSANITY, HIP HOP ABS, FOCUS T25, INSANITY MAX:30 and CIZE. In June 2017, Shaun T released his new program, SHAUN WEEK, which was another mega-hit, reaching 1 million downloads in 6 days. He has hosted several primetime TV se...

Alvogen Pharma US, Inc.

Alvogen is a multinational, privately-owned pharmaceuticals company, focused on developing, manufacturing and distributing generic, brand, over-the-counter brands (OTC) and biosimilar products. With more than 200 pharmaceutical projects in development and registration, the group’s product portfolio consists of a broad range of leading molecules for the ...

BaroFold, Inc.

BaroFold is applying its Pressure Enabled Protein Manufacturing (PreEMT™) Technology to transform inclusion body refolding and improve the efficacy and safety of a wide variety of protein therapeutics for its industry partners. PreEMT technology has been shown to remove protein aggregates, improving product safety for both new-drug entities and biosim...

AAM Biosimilars Council

The Biosimilars Council, a division of the Association for Accessible Medicines (AAM), works to ensure a positive environment for patient access to biosimilar medicines. The Biosimilars Council is a leading source for information about the safety and efficacy of more affordable alternatives to costly brand biologic medicines. Areas of focus include public ...

Electronic Healthcare Network Accreditation Commission (EHNAC)

8. HNAP TPA – Healthcare Network Accreditation Program for Third Party Administrators (Version 1.2)

The Electronic Healthcare Network Accreditation Commission (EHNAC)

7. HNAP TPA – Healthcare Network Accreditation Program for TPAs (Version 1.1)

Alchemia Limited

The Company’s lead program is fondaparinux (a generic version of GlaxoSmithKline’s Arixtra®, a synthetic anticoagulant mainly used for the prevention of deep vein thrombosis). The ANDA for generic fondaparinux was filed for approval with the US FDA in March 2009 and approval is pending. It is partnered with Dr Reddy’s Laboratories for glo...

Abreos Biosciences

Abreos Biosciences is focused on ligand binding assays for biologic and biosimilar drug development, activity validation, authentication, and precision dosing, as well as massively multiplexed biomarker assays. Abreos has already developed reagents for the detection of several drugs currently available on the market such as rituximab, obinutuzumab, trastuz...

Curidium Medica plc

Bringing the right medicine to the right patientThrough understanding the biological, genetic and environmental causes of disease, Curidium believes future drug development will be targeted to more accurately defined subgroups of patients who will benefit from focused drug therapies. This approach has been successfully applied in the areas of cardiovascular and cancer therapeutics. Herceptin®, wh...

Alvogen Inc.

Alvogen is a multinational, privately-owned pharmaceuticals company, focused on developing, manufacturing and distributing generic, brand, over-the-counter brands (OTC) and biosimilar products. With more than 200 pharmaceutical projects in development and registration, the group’s product portfolio consists of a broad range of leading molecules for the ...

ZIP-scan.com

ZIP-scan.com has been providing test correction solutions since 2002. Unlike its major competitors, ZIP-scan.com has always provided its customers with the blank multiple choice answer sheet templates and the ability to print their own bubble test sheets. A demo version of PrintScanScore(TM) is available from the company's website www.ZIP-scan.com.


More From BioPortfolio on "CHMP First Biosimilar Herceptin Another Version Humira"

Quick Search
Advertisement
 

Corporate Database Quicklinks